The fermentation and isolation of a new, non-peptide cholecystokinin antagonist, asperlicin, produced by Aspergillus alliaceus is described. The potent and specific interaction of asperlicin with cholecystokinin receptors was shown using in vitro biochemical assays.
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Cholecystokinin (CCK) is generally recognized as a classical gastro-intestinal transmitter involved in the control of pancreatic and gastric secretion, contraction of the gall bladder and gut motility.
However, in spite of the broad interest in CCK, the few previously reported non-peptide antagonists of this neurotransmitter exhibit in vitro potencies only in the millimolar range. The present report describes the fermentation, isolation, and biological properties of a new, potent non-peptide CCK receptor antagonist from Aspergillus alliaceus. The compound designated as asperlicin is active in the micromolar range.
Fermentation
Material and Methods Cultures: The Aspergillus species initially found to produce asperlicin was obtained from Dr. S. HERNANDEZ of Merck's microbial screening laboratory in Madrid, Spain. It and a natural isolate have been deposited at the American Type Culture Collection (ATCC) with accession numbers ATCC 20655 and ATCC 20656. A. alliaceus strain ATCC 16891 was obtained from the ATCC for this study. Another A. alliaceus strain NRRL 315 was obtained from the Northern Regional Research Laboratories of the United States Department of Agriculture. A Merck source of an A. alliaceus strain descended from NRRL 317 was also used in this study. All other Aspergillus strains used for this study were obtained from S. CURRIE of the Merck Sharp and Dohme Culture Collection.
Fermentation Conditions: Inocula was obtained by growing the culture in a 250-m1 Erlenmeyer flask containing 50 ml of medium I (Table 1) . Inoculum flasks were agitated on a rotary shaker (220 rpm) for 2 days at 28°C and then its contents were used as vegetative inocula (5 % inoculum). For a micro inoculum of spores and mycelia, flasks were incubated further statically at room temperature for 7 -21 days. Spores and mycelia were then diluted with an equal volume of medium II (Table 1) . Flasks were then agitated to disperse and wet the spores. Aliquots of this mixture, that
Results
Fifty-eight strains of 24 genera of Aspergillus were tested for their ability to produce asperlicin.
We have found significant levels of production Aspergillus strains other than those identified as A. alliaceus. Production of asperlicin occurs in a number of fermentation media and under a variety of fermentation conditions. In medium II (Table 1) titers of 15-30,ug/mI are produced by ATCC 20655 and ATCC 20656 after 6 days of incubation. The synthetic medium III (Table 1) supported production of 5-10 ii.g/ml after 6 days of incubation. Supplementing medium III with amino acids (2 g/liter) resulted in titer increases over the control (Table 2) . Notably, supplementation with tryptophan would result in a 5 % inoculum, were used to inoculate production media. Production media, at 40-m1 per unbaffled Erlenmeyer flask, after inoculation, were incubated on a rotary shaker (220 rpm) for 5 -7 days at 28°C. Table 2 . Effect of amino acid supplementation on production of asperlicin. 
Isolation and Purification
The fermentation broth (16 liters) was filtered through a bed of filter-aid. The mycelial cake was extracted twice with vigorous stirring with successive 3-liter portions of ethyl acetate; the broth filtrate was extracted once with 5 liters of ethyl acetate. The combined extracts were concentrated under reduced pressure to an oil which was triturated with 200 ml of ice-cooled petroleum ether; the precipitate that formed was collected by filtration and washed with a fresh 100 ml portion of cold petroleum ether. The solid was stirred with 500 ml methanol, the resulting suspension was filtered and the methanol removed under reduced pressure.
The resultant solid mass was taken up in 30 ml of methylene chloride -methanol, 9: 1, and applied In a larger scale isolation, whole broth (642 liters) was treated batchwise with 64 liters of Amberlite XAD-2 resin (Rohm and Haas Co.). After stirring for one hour, the suspension was filtered through a bed of filter aid. The mycelial resin cake was extracted twice in succession with 340 and 226 liters of acetone, stirring vigorously for 2 hours at ambient temperature. After filtration, the extracts were combined and concentrated under reduced pressure to an oil.
The oil was adsorbed onto 360 g of silica gel by stirring; after washing the silica gel with one liter of petroleum ether on a filtering funnel, the adsorbent was poured carefully onto the top of a silica gel chromatography column packed with 4 kg of silica gel 230400 mesh. The column was washed with 20 liters of methylene chloride which removed most of the non-polar impurities. The compound of interest was eluted from the column with methylene chloride -methanol, 4: 1. The appropriate fractions were pooled and concentrated down to an oil in preparation for the next purification step. Asperlicin (13 pm), alone, did not stimulate amylase release indicating a lack of agonist activity.
However, asperlicin caused a 32-fold parallel shift to the right of the dose response curve for CCKstimulated amylase release from pancreatic tissue (Fig. 3) . The maximal response to CCK-8 in the presence of asperlicin did not differ significantly from CCK-8 alone, indicative of competitive antagonism. The dissociation constant (Kb) for asperlicin as an antagonist of CCK in this system was 0.4 µM.
The data demonstrate that asperlicin is a potent and selective antagonist of peripheral CCK receptors.
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